In addition, we found that patients with PR had higher levels of PD-1 and PD-L1 expression in tumor regions than those with PD, supporting the role and benefit of PD-1/PD-L1 axis blockade in HNSCC. Here, CD274 is linked to head and neck squamous cell carcinoma.